<DOC>
	<DOCNO>NCT02985645</DOCNO>
	<brief_summary>This study intend evaluate efficiency graftless maxillary sinus augmentation concentrate growth factor ( CGF ) utilize `` dynamic implant valve approach '' ( DIVA ) system .</brief_summary>
	<brief_title>Graftless Maxillary Sinus Augmentation With CGF Utilizing DIVA System</brief_title>
	<detailed_description>Crestal bone deficiency posterior maxilla may present therapeutic challenge dental implant require . Sufficient bone volume necessary long term survival implant . The two use surgical technique crestal lateral window . The latter first describe Tatum subsequently , Boyene James 1980 . In original technique , fracture sinus floor , implant place submerged healing phase . The crestal osteotome technique less invasive first describe Summers 1994 . In technique , set osteotomes use prepare implant site , thereby allow bone preservation . Since sinus augmentation describes , bone graft mainstay treatment . Variable bone graft , autograft , allograft , xenograft , alloplasts , combination different graft material , use widely similar result . Nonetheless , successful bone augmentation maxillary sinus , without bone grafting , report human animal study . In 2011 , Dong-Seok et al describe sinus augmentation lateral window approach , use fibrin rich block concentrate growth factor ( CGF ) . The researcher show successful new bone formation sinus , success rate 98 % major complication . Graftless Sinus augmentation relies bioactive mediator stimulate cell proliferation , matrix remodeling , angiogenesis . CGF one late development field , produce process blood sample special centrifuge device . It contain several mediator - platelet-derived growth factor ( PDGF ) , transform growth factor-b1 ( TGF-b1 ) b2 ( TGF-b2 ) , fibroblast growth factor ( FGF ) , vascular endothelial growth factor ( VEGF ) , insulin-like growth factor ( IGF ) . Because CGF dense fibrin matrix , rich growth factor preparation , prove well regenerative capacity versatility . As application CGF , introduction `` dynamic implant valve approach '' ( DIVA ) , minimally invasive approach procedure , enable use close bone augmentation technique . The implant design internal sealing screw might serve drug delivery system via channel . In study , graftless maxillary sinus augmentation CGF perform utilize DIVA system , bone formation periodically measure use panoramic X-ray cone beam computerize tomography ( CBCT ) . In addition , vitro cumulative release select growth factor CGF analyze . The total quantity growth factor check use ELISA kit .</detailed_description>
	<mesh_term>Alveolar Bone Loss</mesh_term>
	<criteria>No medical history disease involve bone metabolism Patients treat prostodontist Healthy oral cavity sinus , good oral hygiene No bone pathology demonstrate Xray Residual subantral bone least 4mm demonstrated computerize tomography ( CT ) The patient participate another clinical study The patient read understand inform consent Medical history disease affect bone metabolism ( Diabetes Mellitus , heart disease , renal failure , osteoporosis ) Medical treatment affect bone metabolism ( Bisphosphonates ) Patients treated anticoagulant ( Coumadin , Pradaxa ) Personal history chemotherapy radiotherapy Patients maxillary sinus pathology Patients lack prostodontic treatment plan Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>CGF</keyword>
	<keyword>sinus augmentation</keyword>
	<keyword>DIVA</keyword>
	<keyword>Platelet-Rich Plasma</keyword>
</DOC>